Prosecution Insights
Last updated: November 20, 2026
Application No. 17/384,006

APPARATUS AND METHOD FOR ADAPTIVE RAMPED CONTROL OF POSITIVE AIRWAY PRESSURE (PAP)

Final Rejection §103
Filed
Jul 23, 2021
Priority
Sep 14, 2016 — AU 2016903685 +1 more
Examiner
WOLFF, ARIELLE R
Art Unit
3785
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
RESMED Pty Ltd.
OA Round
7 (Final)
46%
Grant Probability
Moderate
8-9
OA Rounds
0m
Est. Remaining
80%
With Interview

Examiner Intelligence

Grants 46% of resolved cases
46%
Career Allowance Rate
89 granted / 192 resolved
-23.6% vs TC avg
Strong +33% interview lift
Without
With
+33.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
32 currently pending
Career history
242
Total Applications
across all art units

Statute-Specific Performance

§101
3.4%
-36.6% vs TC avg
§103
57.8%
+17.8% vs TC avg
§102
13.1%
-26.9% vs TC avg
§112
22.2%
-17.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 192 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . This action is in response to the filing on 9/3/2026. Since the previous filing, claims 17-20 have been added and no claims have been amended or cancelled. Thus, claims 1-20 are pending in the application. In regards to the previous 103 Rejections, Applicant’s arguments are not persuasive and these rejections are maintained below. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1-16 is/are rejected under 35 U.S.C. 103 as being unpatentable over Mulcahy (US 2009/0038616) in view of Delache (US 2005/0166920). In regards to claim 1, Mulcahy discloses an apparatus for treating a respiratory disorder comprising (paragraph 2): a breathable gas pressure generating device (paragraph 4 line 4-5), and a controller, including at least one processor (paragraph 20 line 5-6 and paragraph 22 line 5), the controller configured to: collect a plurality of historic pre-sleep parameters concerning a patient initially falling asleep with the apparatus (device remembers and “learns” from data acquired over time to adjust initial settling time, paragraph 97 line 13-17); upon initiation of treatment, control, based on the historic pre-sleep parameters, operation of the breathable gas pressure generating device to provide breathable gas to the patient according to a pre-sleep limit and a pre-sleep profile wherein the pre-sleep limit is set based on at least one of the historic pre-sleep parameters (paragraph 97 line 13-22); the pre-sleep profile includes a plurality of sub-therapeutic pressures defined as a set of pressure amounts and corresponding time points over a duration spanning the pre-sleep limit (paragraph 94-96), and at least one sub-therapeutic pressure of the plurality of sub-therapeutic pressures is an amount of pressure determined based on at least one of the historic pre-sleep parameters (device may deliver ramping set of sub therapeutic pressure prior to patient falling asleep, paragraph 96 line 5-7); and control operation of the breathable gas pressure generating device to provide a plurality of ramping sub-therapeutic pressures based on the pre-sleep limit (paragraph 97 line 13-22); and wherein the controller is configures with a user interface to permit the patient of the apparatus to input to the controller, pre-sleep parameters comprising a pre-sleep pressure, for controlling the provision of the breathable gas to the patient according to the pre-sleep and the pre-seep profile (patient input information into device which results in adjustment of treatment, paragraph 133, claim 79 and 80). While Mulcahy discloses wherein the processor controls operation of the breathable gas pressure generating device to provide a therapeutic pressure to the patient in response to detecting a sleep related event (paragraph 54 and 74-75), it does not explicitly disclose wherein this occurs within the pre-sleep limit. However, Mulcahy does not limit the processor’s ability to respond to sleep related events to any particular sleep stage, instead indicating that it applies this ability to the entire time during which the device is active (paragraph 74-75). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify Mulcahy wherein the processor controls operation of the breathable gas pressure generating device to provide a therapeutic pressure to the patient in response to detecting a sleep related event within the pre-sleep limit as taught by Mulcahy as this would allow the device to respond to a sleep related event occurring after the patient has fallen asleep but before the device has switched modes to ensure that the patient receives the support they need no matter the device mode. In the alternative, if Mulcahy is deemed insufficient to teach the claimed limitations, Delache teaches an apparatus for treating a respiratory disorder (apparatus 1) having a period of subtherapeutic pressure wherein the device is controlled to provide a therapeutic pressure to the patient in response to detecting a sleep related event before the expiration of the subtherapeutic phase (if snoring is detected within ramp period then the device responds by accelerating ramp up to therapeutic pressure, paragraph 28, Fig 2). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify Mulcahy wherein the operation of the breathable gas pressure generating device is controlled to provide a therapeutic pressure to the patient in response to detecting a sleep related event as taught by Delache as this would ensure that the patient receives support when they require it. In regards to claim 2, Mulcahy in view of Delache teaches the device of claim 1 and Mulcahy further discloses wherein the controller is configured to collect the historic pre-sleep parameters by: detecting, with one or more sensors, sleep onset of the patient during use of the breathable gas pressure generating device (sensor determines sleep stage of patient, paragraph 31 line 3-5, controller remembers and learns from input to “snooze” button by user, paragraph 97 line 13-17); and determining a length of time for the sleep onset of the patient (controller adjusts initial settling time based on acquired data, paragraph 97 line 13-17). In regards to claim 3, Mulcahy in view of Delache teaches the device of claim 1 and Mulcahy further discloses wherein the controller is configured to collect the historic pre-sleep parameters by receiving a sleep onset time at a user input device (initial settling time preset, paragraph 95 line 1-4). In regards to claim 4, Mulcahy in view of Delache teaches the device of claim 1 and Mulcahy further discloses wherein the controller is configured to collect the plurality of the historic pre-sleep parameters according to a window timeframe comprising a number of treatment sessions (controller remembers input to “snooze” button and adjusts future initial settling time based on data from multiple prior sessions, paragraph 97 line 13-22, paragraph 114 and 117). In regards to claim 5, Mulcahy in view of Delache teaches the device of claim 4 and Mulcahy further discloses wherein the window timeframe is a rolling window timeframe (the controller is capable of storing and utilizing data collected over a series of treatment sessions counting up from the initial session, therefore the controller could be configured to count back from the current session, paragraph 114 and 117). In regards to claim 6, Mulcahy in view of Delache teaches the device of clam 1 and Mulcahy further discloses wherein the controller is further configured to set a default pre-sleep limit in an absence of a sufficient collection of the historic pre-sleep parameters (initial setting time, paragraph 5 line 1-4). In regards to claim 7, Mulcahy in view of Delache teaches the device of claim 1 and Mulcahy further discloses wherein the controller is further configured to: control a display to provide a prompt for input, the prompt for input including: one or both of (a) at least one of the historic pre-sleep parameters, and (b) at least one statistic concerning the historic pre-sleep parameters (user inputs answers to questions presented on display, paragraph 55 and 62); and determine the pre-sleep limit based on input received in response to the prompt (controller adjusts future treatments based on user input data, paragraph 63). In regards to claim 8, Mulcahy in view of Delache teaches the device of claim 1 wherein the pre-sleep profile includes a first sub-therapeutic pressure and a minimum therapeutic pressure, the minimum therapeutic pressure being higher than the first sub-therapeutic pressure (pressure may ramp up during settling time, paragraph 96 line 3-7), the first sub-therapeutic pressure is to be delivered at a beginning of the pre-sleep limit, and the minimum therapeutic pressure is to be delivered at an end of the pre-sleep limit (paragraph 95). In regards to claim 9, Mulcahy discloses a method for controlling a pressure treatment for a respiratory disorder (paragraph 2) comprising: collecting, by at least one controller, a plurality of historic pre-sleep parameters concerning a patient initially falling asleep with a pressure generating apparatus (paragraph 20 line 5-6, paragraph 97 line 13-17); upon initiation of treatment, controlling, by the at least one controller based on the historic pre-sleep parameters, operation of the pressure generating apparatus to generate a flow of breathable gas at a pressure above atmospheric pressure according to a pre-sleep limit and a pre-sleep profile (paragraph 4 line 4-5, paragraph 97 line 13-22), wherein the pre-sleep limit is set based on at least one of the historic pre-sleep parameters (paragraph 97 line 13-22), the pre-sleep profile includes a plurality of sub-therapeutic pressures defined as a set of pressure amounts versus time having a duration spanning the pre-sleep limit, and the pre-sleep profile comprises at least one sub-therapeutic pressure of the plurality of sub-therapeutic pressures having a pressure amount determined based on at least one of the historic pre-sleep parameters (paragraph 94-96); and control operation of the apparatus to provide a plurality of ramping sub-therapeutic pressures based on the pre-sleep limit (device may deliver ramping set of sub therapeutic pressures prior to patient falling asleep, paragraph 96 line 5-7); and wherein the controller is configures with a user interface to permit the patient of the apparatus to input to the controller, pre-sleep parameters comprising a pre-sleep pressure, for controlling the provision of the breathable gas to the patient according to the pre-sleep and the pre-seep profile (patient input information into device which results in adjustment of treatment, paragraph 133, claim 79 and 80). While Mulcahy discloses wherein the processor controls operation of the breathable gas pressure generating device to provide a therapeutic pressure to the patient in response to detecting a sleep related event (paragraph 54 and 74-75), it does not explicitly disclose wherein this occurs within the pre-sleep limit. However, Mulcahy does not limit the processor’s ability to respond to sleep related events to any particular sleep stage, instead indicating that it applies this ability to the entire time during which the device is active (paragraph 74-75). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify Mulcahy wherein the processor controls operation of the breathable gas pressure generating device to provide a therapeutic pressure to the patient in response to detecting a sleep related event within the pre-sleep limit as taught by Mulcahy as this would allow the device to respond to a sleep related event occurring after the patient has fallen asleep but before the device has switched modes to ensure that the patient receives the support they need no matter the device mode. In the alternative, if Mulcahy is deemed insufficient to teach the claimed limitations, Delache teaches an apparatus for treating a respiratory disorder (apparatus 1) having a period of subtherapeutic pressure wherein the device is controlled to provide a therapeutic pressure to the patient in response to detecting a sleep related event before the expiration of the subtherapeutic phase (if snoring is detected within ramp period then the device responds by accelerating ramp up to therapeutic pressure, paragraph 28, Fig 2). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify Mulcahy wherein the operation of the breathable gas pressure generating device is controlled to provide a therapeutic pressure to the patient in response to detecting a sleep related event as taught by Delache as this would ensure that the patient receives support when they require it. In regards to claim 10, Mulcahy in view of Delache teaches the method of claim 9 and Mulcahy further discloses wherein the collecting the historic pre-sleep parameters comprises: detecting, with one or more sensors, sleep onset of the patient during use of the pressure generating apparatus (sensor determines sleep stage of patient, paragraph 31 line 3-5, controller remembers and learns from input to “snooze” button by user, paragraph 97 line 13-17); and determining a length of time for the sleep onset of the patient (controller adjusts initial settling time based on acquired data, paragraph 97 line 13-17). In regards to claim 11, Mulcahy in view of Delache teaches the method of claim 9 and Mulcahy further discloses wherein the collecting the historic pre-sleep parameters comprises receiving a sleep onset time at a user input device (initial settling time preset, paragraph 95 line 1-4). In regards to claim 12, Mulcahy in view of Delache teaches the method of claim 9 further comprising: collecting, by the at least one controller, the plurality of the historic pre-sleep parameters according to a window timeframe comprising a number of treatment sessions (controller remembers input to “snooze” button and adjusts future initial settling time based on data from multiple prior sessions, paragraph 97 line 13-22, paragraph 114 and 117). In regards to claim 13, Mulcahy in view of Delache teaches the method of claim 12 and Mulcahy further discloses wherein the window timeframe is a rolling window timeframe (the controller is capable of storing and utilizing data collected over a series of treatment sessions counting up from the initial session, therefore the controller could be configured to count back from the current session, paragraph 114 and 117). In regards to claim 14, Mulcahy in view of Delache teaches the method of claim 9 further comprising: setting, by the at least one controller, a default pre-sleep limit in an absence of collection of the historic pre-sleep parameters (initial settling time, paragraph 5 line 1-4). In regards to claim 15, Mulcahy in view of Delache teaches the method of claim 9 further comprising: controlling, by the at least one controller, a display to provide a prompt for input, the prompt for input including: one or both of (a) at least one of the historic pre-sleep parameters, and (b) at least one statistic concerning the historic pre-sleep parameters (user inputs answers to questions presented on display, paragraph 55 and 62); and determining, by the at least one controller, the pre-sleep limit based on input received in response to the prompt (controller adjusts future treatments based on user input data, paragraph 63). In regards to claim 16, Mulcahy in view of Delache teaches the method of claim 9 wherein the pre-sleep profile includes a first sub-therapeutic pressure to be delivered at a first time during the pre-sleep limit and minimum therapeutic pressure to be delivered at a second time during the pre-sleep limit, the minimum therapeutic pressure being higher than the first sub-therapeutic pressure (pressure may ramp up during settling time, paragraph 96 line 3-7), the first time being at a beginning of the pre-sleep limit, and the second time being at an end of the pre-sleep limit (paragraph 95). Claim(s) 17-20 is/are rejected under 35 U.S.C. 103 as being unpatentable over Mulcahy (US 2009/0038616) in view of Delache (US 2005/0166920) as applied above and in further view of Ahmad (US 2015/0231349). In regards to claim 17, Mulcahy in view of Delache teaches the device of claim 1. Mulcahy does not teach wherein the controller is further configured to, in response to detecting sleep onset prior to completion of the pre-sleep profile during a current treatment session, determine a new profile for ramping pressure from a pressure being delivered when sleep onset is detected to a minimum therapeutic pressure. However, Ahmad teaches an apparatus wherein the controller is further configured to, in response to detecting sleep onset prior to completion of the pre-sleep profile during a current treatment session, determine a new profile for ramping pressure from a pressure being delivered when sleep onset is detected to a minimum therapeutic pressure (detection of sleep state triggers accelerated ramp up to treatment pressure, paragraph 45, Fig 8). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify Mulcahy wherein the controller is further configured to, in response to detecting sleep onset prior to completion of the pre-sleep profile during a current treatment session, determine a new profile for ramping pressure from a pressure being delivered when sleep onset is detected to a minimum therapeutic pressure as taught by Ahmad as this would allow the device to respond quickly to the needs of the user. In regards to claim 18, Mulcahy in view of Delache and Ahmad teaches the device of claim 17 and the combination further teaches wherein the new profile takes a shorter amount of time than the pre-sleep profile to reach the minimum therapeutic pressure (Ahmad: detection of sleep state triggers accelerated ramp up to treatment pressure, paragraph 45, Fig 8). In regards to claim 19, Mulcahy in view of Delache teaches the method of claim 9. Mulcahy does not teach further comprising: in response to detecting sleep onset prior to completion of the pre-sleep profile during a current treatment session, determining a new profile for ramping pressure from a pressure being delivered when sleep onset is detected to a minimum therapeutic pressure. However, Ahmad teaches a method further comprising: in response to detecting sleep onset prior to completion of the pre-sleep profile during a current treatment session, determining a new profile for ramping pressure from a pressure being delivered when sleep onset is detected to a minimum therapeutic pressure (detection of sleep state triggers accelerated ramp up to treatment pressure, paragraph 45, Fig 8). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify Mulcahy to further comprise: in response to detecting sleep onset prior to completion of the pre-sleep profile during a current treatment session, determining a new profile for ramping pressure from a pressure being delivered when sleep onset is detected to a minimum therapeutic pressure as taught by Ahmad as this would allow quick response to adjust treatment to suit the needs of the user. In regards to claim 20, Mulcahy in view of Delache and Ahmad teaches the method of claim 9 and the combination further teaches wherein the new profile takes a shorter amount of time than the pre-sleep profile to reach the minimum therapeutic pressure (Ahmad: detection of sleep state triggers accelerated ramp up to treatment pressure, paragraph 45, Fig 8). Response to Arguments In regards to the arguments concerning independent claims 1 and 9, these arguments have been previously addressed in the Interview of 9/9/2026 and are restated below with minor modification for clarity. Applicant argues that Mulcahy teaches away from the claimed invention based on disclosure in Mulcahy which discusses rise to therapeutic pressure "following" a predetermined time period, which Applicant alleges would teach away from the limitation of the device responding to a sleep event during the pre-sleep limit. Examiner disagrees, and interprets this passage as describing an intended normal operation of the device under baseline conditions without any interruption or deviation during this time period. Applicant further argues against Delache as it does not reference any pre-sleep limit and the time limit of Delache is not based on any pre-sleep parameters. Examiner notes that Delache is not being called for the determination of the time limit being based on pre-sleep parameters, that limitation being previously addressed by Mulcahy, and elaborated on the prior rejection wherein the stated sub-therapeutic pressure time period is intended to equate to the "pre-sleep limit" as they are both initial periods of sub-therapeutic pressure that increase to full therapeutic pressure at the end of the time period, and Delache is called to teach the concept of the device being able to respond to the needs of the user during this sub-therapeutic time period and before said time period’s expiration by altering the applied therapy as needed. Arguments concerning dependent claims are in reference to their dependency from above argued claim 1 and claim 9 and are therefore addressed in the response above. Arguments concerning the new claims are addressed in the new rejections entered above. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Arielle Wolff whose telephone number is (571)272-8727. The examiner can normally be reached Mon-Fri 8:00-4:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Kendra Carter can be reached on (571) 272-9034. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ARIELLE WOLFF/ Examiner, Art Unit 3785 /KENDRA D CARTER/ Supervisory Patent Examiner, Art Unit 3785
Read full office action

Prosecution Timeline

Show 14 earlier events
Oct 02, 2025
Response after Non-Final Action
Nov 03, 2025
Non-Final Rejection mailed — §103
Mar 18, 2026
Response Filed
Jun 01, 2026
Non-Final Rejection mailed — §103
Sep 03, 2026
Response Filed
Sep 09, 2026
Examiner Interview Summary
Sep 09, 2026
Applicant Interview (Telephonic)
Nov 04, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12773511
VENTILATION TUBE INTRODUCER
2y 6m to grant Granted Oct 27, 2026
Patent 12766281
SYSTEM FOR MONITORING TRACHEOSTOMY AIRFLOW
6y 2m to grant Granted Oct 20, 2026
Patent 12721775
HIGH FREQUENCY CHEST WALL OSCILLATION PUMP
2y 2m to grant Granted Sep 01, 2026
Patent 12678368
Systems and Methods for Providing Resuscitation Guidance based on Physical Features of a Patient Measured During an Acute Care Event
7y 0m to grant Granted Jul 14, 2026
Patent 12661470
NASAL MASK INTERFACE ASSEMBLY
2y 9m to grant Granted Jun 23, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

8-9
Expected OA Rounds
46%
Grant Probability
80%
With Interview (+33.3%)
3y 6m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 192 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month